financetom
Business
financetom
/
Business
/
India sends navigation satellite into orbit on ISRO rocket in landmark launch
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
India sends navigation satellite into orbit on ISRO rocket in landmark launch
Jan 28, 2025 8:06 PM

BENGALURU, Jan 29 (Reuters) - India successfully

launched into orbit on Wednesday a new navigation satellite

aboard a home-grown rocket, strengthening its independent

satellite positioning system at a time when space-based

technologies are becoming increasingly critical.

The NVS-02 satellite lifted off from the Satish Dhawan Space

Centre in Sriharikota about 6:23 a.m. IST (0053 GMT) aboard the

GSLV-F15 rocket, marking the latest step in India's efforts to

expand its Navigation with Indian Constellation (NavIC) system.

Designed to provide positioning services over India and

surrounding regions, NavIC has been positioned by the country as

India's answer to the U.S. Global Positioning System (GPS),

China's BeiDou, the European Galileo, and Russia's GLONASS.

The launch, ISRO's 100th, comes as competition in space

intensifies, with countries racing to expand satellite networks

that power everything from defence operations to smartphone

navigation and financial transactions.

Jitendra Singh, India's minister of Science and Technology

said, "It's a privilege to be associated with the Department of

Space at the historic moment of this record feat."

In 2024, the United States led with 145 space launches,

driven largely by SpaceX, while China followed with 68,

according to industry data. India, historically a smaller

player, is increasing its launch cadence, with ISRO planning 30

missions by March 2025.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Mullen Automotive Shares Are Gaining Today
Why Mullen Automotive Shares Are Gaining Today
Sep 6, 2024
Mullen Automotive, Inc. ( MULN ) shares are trading higher on Wednesday. Today, the company announced the dispatch of the first batch of vehicles as part of a substantial $210 million contract with Volt Mobility, a UAE-based company. Under this agreement, Mullen said it will start recognizing revenue in the first fiscal quarter beginning October 1, 2024. The contract involves...
HSBC Faces Renewed Regulatory Scrutiny Over Data Practices And Risk Management: Report
HSBC Faces Renewed Regulatory Scrutiny Over Data Practices And Risk Management: Report
Sep 6, 2024
HSBC Holdings, plc ( HSBC ). shares are trading higher on Wednesday. UK regulators have reportedly instructed HSBC ( HSBC ) to reassess its data collection and monitoring practices, focusing on the data crucial for its risk management systems in investment banking and trading. The Bank of England’s Prudential Regulation Authority has directed HSBC ( HSBC ) to commission a...
Centene's Iowa Total Care Gets 4-Year Medicaid Contract
Centene's Iowa Total Care Gets 4-Year Medicaid Contract
Sep 6, 2024
12:21 PM EDT, 09/04/2024 (MT Newswires) -- Centene ( CNC ) said Wednesday that its Iowa Total Care unit is selected by the Iowa Department of Health and Human Services for continued provision of Medicaid managed care services. The services will be provided under the Iowa Health Link program, according to Centene ( CNC ). The contract will begin July...
Psyence Biomedical (PBM) Stock Is Down 30%: What's Going On?
Psyence Biomedical (PBM) Stock Is Down 30%: What's Going On?
Sep 6, 2024
Psyence Biomedical Ltd ( PBM ) shares are trading lower by 28.6% to $0.25 during Wednesday’s session. The company earlier announced it entered into an exclusive licensing agreement with PsyLabs, a company specializing in psychedelic pharmaceutical ingredients. Under this agreement, PsyLabs will provide Psyence Biomed with pharmaceutical-grade, nature-derived psilocybin for use in clinical trials and potential commercialization. Psyence Biomed plans...
Copyright 2023-2025 - www.financetom.com All Rights Reserved